Latest News

11.14.19

Understanding the Eye’s ‘Plumbing’ Could Lead to Future Treatments for Glaucoma, Other Diseases

Source: University of Arizona Health Sciences

11.14.19

EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development

Source: EyePoint Pharmaceuticals

11.14.19

Iveric bio Initiating Second Pivotal Clinical Trial of Zimura in GA with 1Q 2020 Targeted for First Patient Enrolled

Source: Iveric bio

11.14.19

Armenian EyeCare Project Surpasses Milestone of 10,000 Patients Screened Using Artificial Intelligence Eye Screening Technology

11.14.19

Solving a Medical Mystery Crucial to Future Space Travel

Source: Medscape

11.13.19

Bausch + Lomb and TerraCycle Announce Donation of New Custom Training Modules to Guide Dog Foundation

Source: Bausch + Lomb

11.13.19

ELT Sight Acquires Assets and IP of MLase AG Excimer Ophthalmic Laser System for Glaucoma Surgery

Source: ELT Sight

11.13.19

Eversight Awarded $50,000 to Investigate Cell Expansion to Address Global Cornea Shortage

Source: Eversight

11.12.19

Bloomberg: Allergan CEO’s Best Career Decision Was Taking a ‘Huge’ Pay Cut

Source: Bloomberg

11.12.19

Envision Announces Dates, Calls for Submissions for 2020 Conferences

Source: Envision

11.11.19

Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in China

Source: Novaliq

11.08.19

Teprotumumab Improves Bulging, QOL in Thyroid Eye Disease

Source: Medscape News

11.08.19

Intravitreous Ranibizumab Cost-Effective for Some With Proliferative Diabetic Retinopathy

Source: Reuters Health

11.07.19

Leica Microsystems and Precision Lens Sign Agreement to Expand Leica Ophthalmic Portfolio in the U.S. Midwest

Source: Leica Microsystems

11.07.19

Optina Diagnostics and Wagner Macula Retina Center to Conduct a Study to Identify the Causes of Memory Loss Through Eye Diagnostics

Source: Optina Diagnostics

11.07.19

Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol Eye Drops

Source: Ocuphire Pharma

View more stories